Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 1, 2001

View Archived Issues

Infliximab effective against plaque-type psoriasis

Enzyme replacement shown effective in Fabry's disease

Meta-analysis shows HRT reduces nonvertebral fractures, especially in younger women

Thalidomide improves survival in multiple myeloma patients

Antigenics significantly expands product portfolio during Q2 2001

Esperion Therapeutics updates clinical trial programs

BioErgonomics and Loma Linda enter agreement to develop AD diagnostic

Results reported from phase II OvaRex ovarian cancer trial

Amarin and Elan announce partnership to establish Parkinson's franchise

Sanguine's synthetic red blood cell product shows good stability

Microcide and Althexis sign merger agreement

British Biotech broadens product portfolio during past year

Kos Pharmaceuticals receives approvable letter for niacin/lovastatin tablets

Peregrine and Oakwood Labs to develop tumor necrosis therapy using anticancer liposome technology

GPI-1046 protects nigral neurons in mice

Novartis's TCH-346 is neuroprotective against MPTP toxicity in monkeys

Bico acquires rights for several rapid HIV diagnostic tests

Lead compounds discovered in collaboration between Otsuka and Pharmacopeia

New advanced tool for protein identification will aid in rapid drug target identification

AstraZeneca patents new insulin-sensitizing agents

Novel series of aminopropylphosphinic acid derivatives described by AstraZeneca

Compounds with neurotrophic and neuroprotective activity disclosed by Bristol-Myers Squibb

New derivatives for reversing drug-induced neuromuscular block presented by Azko Nobel

Ono Pharmaceutical describes new chemokine receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...